Quantcast

Latest Novartis Stories

2014-10-21 08:28:24

Through music and resources Our Voice in Song(TM) inspires people living with relapsing MS to become more active managers of their disease EAST HANOVER, N.J., Oct. 21, 2014 /PRNewswire/ -- Today Novartis Pharmaceuticals Corporation launched a new multifaceted multiple sclerosis (MS) awareness campaign aimed to motivate people with relapsing MS to take charge of their disease. The campaign, Our Voice in Song(TM), features inspirational advocate and music artist David Osmond, who...

2014-10-20 16:27:09

- Biologics License Application (BLA) for secukinumab, a "first-in-class" IL-17A inhibitor, is currently under FDA review with an anticipated action date in early 2015 EAST HANOVER, N.J., Oct. 20, 2014 /PRNewswire/ -- Novartis announced the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) to the US Food and Drug Administration (FDA) today voted 7 to 0 to support the approval of AIN457 (secukinumab), a selective interleukin-17A (IL-17A) inhibitor, for the treatment...

2014-10-20 08:31:57

SAN DIEGO, Oct. 20, 2014 /PRNewswire/ -- AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies, today announced the appointment of Marco Londei, M.D. as Chief Development Officer. Dr. Londei will lead the preclinical and clinical development of AnaptysBio's proprietary antibody pipeline. http://photos.prnewswire.com/prnvar/20111205/SF16052LOGO "We are pleased to welcome Dr. Londei to AnaptysBio's executive leadership team," said Hamza Suria,...

2014-10-16 00:20:40

BASEL, Switzerland, Oct. 16, 2014 /PRNewswire/ -- -- Integrated sales up 3 percent[1], with growth in all regions -- ELATUS(TM) orders exceed $200m in first nine months -- Full year integrated sales growth target of 6 percent maintained Group sales, including Lawn and Garden, increased by 2 percent at constant exchange rates in the third quarter of 2014. The increase in reported sales was also 2 percent. For the first nine months of 2014, sales rose by 3 percent at constant...

2014-10-15 16:30:25

- Preliminary study results show 27 of 30 pediatric and adult patients with relapsed/refractory (r/r) ALL (90%) experienced complete remissions with personalized cell therapy, CTL0191 EAST HANOVER, N.J., Oct. 15, 2014 /PRNewswire/ -- Novartis and the University of Pennsylvania's Perelman School of Medicine (Penn) today announced preliminary results from two pilot clinical trials published in The New England Journal of Medicine (NEJM) evaluating the efficacy and safety of CTL019 in patients...

2014-10-09 16:26:01

LONDON, Oct. 9, 2014 /PRNewswire/ -- The global market for seed treatment in cotton is forecast to maintain the slowest 2014-2020 CAGR of 5.3% in comparison to other crop types. With an estimated share of 46.7% in 2014, North America is the largest market for seed treatment in cotton applications, though Asia-Pacific is expected to register the fastest corresponding period CAGR of 7.3%.The market for seed treatment gains in significance due to a number of factors, prominent among...

2014-10-09 16:25:58

LONDON, Oct. 9, 2014 /PRNewswire/ -- The global market for seed treatment in rice is likely to post a relatively modest CAGR of 6.1% during the 2014-2020 analysis period. While North America is and would remain the largest market for seed treatment in rice, Asia-Pacific's demand is slated to exceed all other regions in terms of recording a CAGR of 8.5% between 2014 and 2020.The market for seed treatment gains in significance due to a number of factors, prominent among which are...

2014-10-09 16:25:51

LONDON, Oct. 9, 2014 /PRNewswire/ -- The North American market for seed treatment in cotton is likely to reach US$74.8 million by 2020 from an estimated US$55.6 million in 2014 at a CAGR of 5%. Though United States is the largest market for seed treatment in cotton in the region, with an estimated 2014 share of 89.6%, Mexican demand for the same is slated to register the fastest 2014-2020 CAGR of 5.3%.The market for seed treatment gains in significance due to a number of factors,...

2014-10-09 16:25:48

LONDON, Oct. 9, 2014 /PRNewswire/ -- The global market for insecticide seed treatment is estimated at US$1.3 billion in 2014 and further forecast to post a CAGR of 6.1% during 2014-2020 in reaching a projected US$1.8 billion by 2020. While North America is the largest global market for insecticide seed treatment, accounting for an estimated 48% share in 2013, Asia-Pacific is anticipated to record the fastest similar period CAGR of 8.3%.The market for seed treatment gains in...

2014-10-09 16:25:44

LONDON, Oct. 9, 2014 /PRNewswire/ -- The global market for fungicide seed treatment is poised to post the fastest CAGR of 7.1% between 2014 and 2020 among all categories of chemical seed treatments. Though North America, with an estimated 2014 share of 49%, constitutes the largest market for fungicide seed treatment worldwide, demand for the same is expected to be the fastest in Asia-Pacific, which is forecast to maintain a 2014-2020 CAGR of 8.9%.The market for seed treatment gains in...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.